Aptorum Group Ltd Class A is a biotechnology business based in the US. Aptorum Group Ltd Class A shares (APM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.86 – a decrease of 6.43% over the previous week.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.86 |
|---|---|
| 52-week range | $0.46 - $5.64 |
| 50-day moving average | $0.91 |
| 200-day moving average | $1.62 |
| Wall St. target price | $80.00 |
| PE ratio | 2.9677 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.31 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.89 from 2025-05-07
| 1 week (2025-05-01) | -3.26% |
|---|---|
| 1 month (2025-04-09) | 20.27% |
| 3 months (2025-02-07) | -27.05% |
| 6 months (2024-11-08) | -27.64% |
| 1 year (2024-05-09) | -82.20% |
|---|---|
| 2 years (2023-05-08) | -75.55% |
| 3 years (2022-05-06) | 9.5 |
| 5 years (2020-05-08) | 32 |
Valuing Aptorum Group Ltd Class A stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aptorum Group Ltd Class A's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aptorum Group Ltd Class A's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Aptorum Group Ltd Class A shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Gross profit TTM | $5,251 |
|---|---|
| Return on assets TTM | -27.45% |
| Return on equity TTM | -3.04% |
| Profit margin | 0% |
| Book value | $4.14 |
| Market Capitalization | $6.6 million |
TTM: trailing 12 months
We're not expecting Aptorum Group Ltd Class A to pay a dividend over the next 12 months.
Aptorum Group Ltd Class A's shares were split on a 1:10 basis on 22 January 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aptorum Group Ltd Class A shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aptorum Group Ltd Class A shares which in turn could have impacted Aptorum Group Ltd Class A's share price.
Over the last 12 months, Aptorum Group Ltd Class A's shares have ranged in value from as little as $0.46 up to $5.64. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aptorum Group Ltd Class A's is -0.379. This would suggest that Aptorum Group Ltd Class A's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aptorum Group Ltd Class A has bucked the trend.
Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products for the treatment of oncology and infectious diseases. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; ALS-1 to treat viral infections caused by influenza virus A; and ALS-2/3 for the treatment of gram+ve bacterial infections. The company is also developing RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, and other disease areas. In addition, it is involved in the operation of medical clinics.
We dug through 60 years of Berkshire Hathaway annual shareholder letters to bring you 9 lessons from Warren Buffett: “The Oracle of Omaha.”
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.